Showing 81 - 100 results of 262 for search '"Oxycodone"', query time: 0.09s Refine Results
  1. 81

    HIV-1 Tat Dysregulates the Hypothalamic-Pituitary-Adrenal Stress Axis and Potentiates Oxycodone-Mediated Psychomotor and Anxiety-Like Behavior of Male Mice by Mohammed F. Salahuddin, Fakhri Mahdi, Jason J. Paris

    Published 2020-11-01
    “…We hypothesized that HPA dysregulation may contribute to Tat-mediated interactions with oxycodone, a clinically-used opioid often prescribed to HIV patients. …”
    Get full text
    Article
  2. 82
  3. 83

    State-level variation in distribution of oxycodone and opioid-related deaths from 2000 to 2021: an ecological study of ARCOS and CDC WONDER data in the USA by Kenneth L McCall, Brian J Piper, Jove Graham, Jay P Solgama, Edward Liu, Mellar Davis

    Published 2024-03-01
    “…Florida stood out in practitioner-distributed oxycodone, with an elevation of almost 15-fold the average state from 2006 to 2010. …”
    Get full text
    Article
  4. 84
  5. 85

    Comparison on the efficacy of immediate release oxycodone and tramadol in reducing postoperative pain, nausea and vomiting in post laparotomy patients weaned from PCA morphine by Kumar, Shyamala a/p V.

    Published 2016
    “…Introduction : The introduction of oxycodone into the Malaysian health care system in recent years has opened up another option for postoperative pain relief. …”
    Get full text
    Thesis
  6. 86
  7. 87
  8. 88
  9. 89
  10. 90
  11. 91
  12. 92
  13. 93
  14. 94
  15. 95
  16. 96

    Effect of oxycodone combined with ultrasound-guided thoracic paravertebral nerve block on postoperative analgesia in patients with lung cancer undergoing thoracoscopic surgery: protocol for a randomised controlled study by Zheng Liu, Jian Su, Yujie Wang, Guanghan Wu, Hai Feng, Xiumin Wei, Pengcai Shi

    Published 2023-10-01
    “…Participants will be randomly assigned to four groups in a 1:1:1:1 ratio: OCA group (oxycodone: 0.5 mg/kg), OCB group (oxycodone: 1.0 mg/kg), OCC group (oxycodone: 1.5 mg/kg) and one sufentanil group (sufentanil: 2 µg/kg). …”
    Get full text
    Article
  17. 97
  18. 98

    Clinical evaluation of PF614, a novel TAAP prodrug of oxycodone, versus OxyContin in a multi‐ascending dose study with a bioequivalence arm in healthy volunteers by D. Lynn Kirkpatrick, Cari Evans, Linda A. Pestano, Jeffrey Millard, Matthew Johnston, Emily Mick, William K. Schmidt

    Published 2024-03-01
    “…Abstract PF614, a trypsin‐activated abuse protection oxycodone prodrug designed to reduce recreational drug abuse, was compared to OxyContin for safety and pharmacokinetics (PKs) of plasma oxycodone following oral administration. …”
    Get full text
    Article
  19. 99
  20. 100